Financial Performance - For the quarter ended September 2024, Intuitive Surgical, Inc. reported revenue of $2.04 billion, reflecting a 16.9% increase year-over-year [1] - EPS for the quarter was $1.84, up from $1.46 in the same quarter last year [1] - The reported revenue exceeded the Zacks Consensus Estimate of $2.01 billion by 1.17%, while the EPS surpassed the consensus estimate of $1.65 by 11.52% [1] Key Metrics - Total System Units Placed by the company reached 379, exceeding the average estimate of 316 by analysts [2] - The installed base of the Da Vinci Surgical System was 9,539, slightly above the estimated 9,498 [2] - In the United States, Total System Units Placed were 219, surpassing the average estimate of 160 [2] - Revenue from Products (Instruments and accessories and Systems) was $1.71 billion, compared to the estimated $1.66 billion, marking a 17.8% increase year-over-year [2] - Revenue from Services was $328.90 million, slightly below the average estimate of $332.31 million, but still representing a 12.3% year-over-year increase [2] - Revenue from Systems was $445 million, exceeding the estimated $417.75 million, with a year-over-year increase of 17.3% [2] - Revenue from Instruments and accessories was $1.26 billion, compared to the estimated $1.24 billion, reflecting an 18% year-over-year change [2] - Gross profit from Services was $220.10 million, below the estimated $225.36 million, while Gross profit from Products was $1.15 billion, exceeding the estimate of $1.10 billion [2] Stock Performance - Shares of Intuitive Surgical have returned -3.3% over the past month, contrasting with the Zacks S&P 500 composite's +3.8% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]
Compared to Estimates, Intuitive Surgical (ISRG) Q3 Earnings: A Look at Key Metrics